Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program
NCT02933346
·
clinicaltrials.gov ↗
COMPLETED
Status
907
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Nivolumab
Long-term Adverse Effects
Sponsor
Intergroupe Francophone de Cancerologie Thoracique
Collaborators
[object Object]